Vaccine

Showing 15 posts of 293 posts found.

J&J’s one-shot COVID-19 vaccine submitted to the EU

February 17, 2021
Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine

Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.

North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data

February 16, 2021
Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine

North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …

South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines

February 16, 2021
Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea

South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.

Pfizer COVID-19 vaccine proven 94% effective in biggest study yet

February 15, 2021
Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus

The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …

credit_-_daniel_leal-olivas-afp

COVID-19 vaccine data leaked online by hackers, EMA says

January 14, 2021
EMA, Pfizer, Vaccine, data

The EMA has confirmed that data relating to COVID-19 medicines and vaccines that was stolen by hackers in December have …

Trial of potential new COVID-19 treatment begins in UK

January 13, 2021
Research and Development COVID-19, Synairgen, Vaccine

A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …

moderna_norwood_plant

Switzerland approves Moderna’s COVID-19 vaccine

January 13, 2021
Research and Development COVID-19, Moderna, Vaccine

Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …

astrazeneca-sign

AstraZeneca seeks EU approval for COVID-19 vaccine

January 12, 2021
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …

vaccination

Seven mass vaccination sites open in England

January 11, 2021
Sales and Marketing COVID-19, UK, Vaccine

Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …

Pfizer’s COVID-19 vaccine protects against variants, research shows

January 8, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …

Bayer and CureVac to collaborate on COVID-19 vaccine candidate

January 8, 2021
Medical Communications Bayer, COVID-19, Vaccine

Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …

sputnik-v-covid-19-vaccine-scaled-e1599484511213

Bolivia registers Russia’s Sputnik V COVID-19 vaccine

January 7, 2021
COVID-19, Vaccine

Bolivia’s state agency for medicines and health technologies (AGEMED) has registered Russia’s Sputnik V COVID-19 vaccine under emergency use authorisation. …

moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …

covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 6, 2021
Research and Development COVID-19, Vaccine

In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …

who_flag

WHO recommends against 12-week delay for COVID-19 vaccine doses

January 6, 2021
Research and Development COVID-19, Vaccine, WHO

The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …

The Gateway to Local Adoption Series

Latest content